RSS

Bill & Melinda Gates Foundation

A pharma technology company has received a $14.3 million grant from the Bill & Melinda Gates Foundation to help increase the availability of measles and rubella (M&R) vaccines in low-and middle-income countries (LMICs). Read more

News